Get the latest news on IMV stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on IMVIF performance

Latest IMV Stock News | OTC:IMVIF | Benzinga

IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.

Comments

IMV Stock News

News

Latest IMV Stock News | OTC:IMVIF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga